5 reports

The company operates in one business segment.

  • Molecular Diagnostic
  • Tuberculosis
  • United States
  • Company
  • QIAGEN N.V.

GSK will have the option to license tuberculosis compounds and would be responsible for all further development and commercialization.

  • Tuberculosis
  • United States
  • Company
  • Corporate Finance
  • Anacor Pharmaceuticals, Inc.

PARTNER ##: DR.

  • Tuberculosis
  • United States
  • Company
  • Corporate Finance
  • TapImmune Inc.

DEAL IN BRIEF Partner ## Partner ## Partner ## Deal status Deal category Deal sub-category Date of announcement BioFocus DPI Limited The Global Alliance for TB Drug Development Galapagos NV Announced Partnership Other Jan ##, 2010 COMPANY INFORMATION: PARTNERS PARTNER ##: THE GLOBAL AL

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Tuberculosis
  • BioFocus DPI Limited

DEAL IN BRIEF PARTNER ##: ONYX SCIENTIFIC, LTD.

  • Tuberculosis
  • United States
  • Company
  • M&A
  • Cyprotex PLC